ATE422673T1 - Test für übertragbare spongiforme encephalopathien - Google Patents

Test für übertragbare spongiforme encephalopathien

Info

Publication number
ATE422673T1
ATE422673T1 AT02716273T AT02716273T ATE422673T1 AT E422673 T1 ATE422673 T1 AT E422673T1 AT 02716273 T AT02716273 T AT 02716273T AT 02716273 T AT02716273 T AT 02716273T AT E422673 T1 ATE422673 T1 AT E422673T1
Authority
AT
Austria
Prior art keywords
prion protein
spongiform encephalopathies
sample
test
protein
Prior art date
Application number
AT02716273T
Other languages
English (en)
Inventor
Michael O'connor
Original Assignee
Enfer Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enfer Technology Ltd filed Critical Enfer Technology Ltd
Application granted granted Critical
Publication of ATE422673T1 publication Critical patent/ATE422673T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4709Amyloid plaque core protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2828Prion diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Fats And Perfumes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT02716273T 2001-01-19 2002-01-18 Test für übertragbare spongiforme encephalopathien ATE422673T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE20010042A IES20010042A2 (en) 2001-01-19 2001-01-19 Test for transmissible spongiform encephalopathies

Publications (1)

Publication Number Publication Date
ATE422673T1 true ATE422673T1 (de) 2009-02-15

Family

ID=11042715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02716273T ATE422673T1 (de) 2001-01-19 2002-01-18 Test für übertragbare spongiforme encephalopathien

Country Status (12)

Country Link
US (1) US20040115730A1 (de)
EP (1) EP1352248B1 (de)
JP (2) JP3930807B2 (de)
KR (1) KR20040010581A (de)
AT (1) ATE422673T1 (de)
AU (1) AU2002226643B2 (de)
BR (1) BR0206593A (de)
CA (1) CA2434879C (de)
DE (1) DE60231106D1 (de)
IE (1) IES20010042A2 (de)
NZ (1) NZ526984A (de)
WO (1) WO2002057789A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003278364A1 (en) * 2002-11-01 2004-05-25 D-Gen Limited Prion decontamination
AU2003285969A1 (en) * 2002-11-25 2004-06-18 Albert Missbichler Method for detecting membrane-bound and/or amyloid proteins
EP1462804A1 (de) * 2003-03-25 2004-09-29 Stichting Sanquin Bloedvoorziening Verfahren zum Nachweis von pathogenen Prionenproteinen
NZ543371A (en) * 2003-04-04 2008-04-30 Pathogen Removal And Diagnosti Prion protein binding materials and methods of use
DE10354207B8 (de) * 2003-11-20 2006-06-14 Priontype Gmbh & Co.Kg Verfahren zum Nachweis von pathologisch veränderten Prion-Proteinen (PrPSc) und Kit zur Durchführung des Verfahrens
ES2534471T3 (es) 2006-10-27 2015-04-23 E.I. Du Pont De Nemours And Company Método para la descontaminación de priones
GB201015569D0 (en) * 2010-09-16 2010-10-27 Medical Res Council Blood assay for prions
ES2736024T5 (es) 2014-06-12 2022-07-01 Biomerieux Deutschland Gmbh Desenmascarar endotoxinas en solución
ES2662957T3 (es) 2014-06-12 2018-04-10 Hyglos Invest Gmbh Desenmascaramiento de endotoxinas en disolución
CN115261368A (zh) * 2022-08-16 2022-11-01 北京思尔成生物技术有限公司 一种即用型胃蛋白酶工作液及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3921839A1 (de) * 1989-07-03 1991-01-17 Henkel Kgaa Enzymatischer reiniger
US5090084A (en) * 1989-08-30 1992-02-25 Cleanline Corporation Cleaning roller for surfaces and apparatus for use therewith
AT408191B (de) * 1991-08-19 2001-09-25 Haemosan Erzeugung Pharmazeuti Verfahren zur inaktivierung von prionen
ES2128362T3 (es) * 1991-12-03 1999-05-16 Proteus Molecular Design Fragmentos de proteinas de prion.
US5914114A (en) * 1995-06-02 1999-06-22 The United States Of America As Represented By The Secretary Of The Army Method of raising antibodies against E. coli of the family CS4-CFA/I
DE69818388T2 (de) * 1997-02-06 2004-07-01 Enfer Technology Ltd. Immunoassay für spongiforme encephalopathien
EP0861900A1 (de) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunologischer Nachweis von Prionen
US6150172A (en) * 1999-01-08 2000-11-21 The United States Of America As Represented By The Secretary Of Agriculture Method and kit for extracting prion protein

Also Published As

Publication number Publication date
IES20010042A2 (en) 2002-12-11
AU2002226643B2 (en) 2006-11-02
US20040115730A1 (en) 2004-06-17
NZ526984A (en) 2005-04-29
WO2002057789A8 (en) 2004-03-25
BR0206593A (pt) 2004-02-25
JP2004524523A (ja) 2004-08-12
DE60231106D1 (en) 2009-03-26
JP2007017449A (ja) 2007-01-25
WO2002057789A3 (en) 2003-03-13
JP3930807B2 (ja) 2007-06-13
EP1352248A2 (de) 2003-10-15
EP1352248B1 (de) 2009-02-11
CA2434879A1 (en) 2002-07-25
WO2002057789A2 (en) 2002-07-25
KR20040010581A (ko) 2004-01-31
CA2434879C (en) 2008-12-09

Similar Documents

Publication Publication Date Title
Komatsu et al. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients
Shariat-Madar et al. Recombinant prolylcarboxypeptidase activates plasma prekallikrein
Langerholc et al. Inhibitory properties of cystatin F and its localization in U937 promonocyte cells
ATE422673T1 (de) Test für übertragbare spongiforme encephalopathien
JP7758766B2 (ja) 完全長の高分子量キニノーゲン(hmwk)と切断されたhmwkとを区別するためのペプチド定量アッセイ
Wysocka et al. Three wavelength substrate system of neutrophil serine proteinases
DK0891553T3 (da) Fremgangsmåde til påvisning af overførbare spogniforme encephalopatier
Zavašnik-Bergant et al. Salivary tick cystatin OmC2 targets lysosomal cathepsins S and C in human dendritic cells
Simoes et al. Plasma kallikrein‐kinin system contributes to peripheral inflammation in temporal lobe epilepsy
ATE272842T1 (de) Diagnose spongiformer encephalopathie
Zaidi et al. A new approach for distinguishing cathepsin E and D activity in antigen‐processing organelles
Monroe et al. Characterization of IXINITY®(Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine‐148 Polymorph
Pacheco et al. Involvement of lysosomal cathepsins in the cleavage of DNA topoisomerase I during necrotic cell death
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
FR2849205B1 (fr) Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification
WO2002035238A8 (en) Method of determining prion strain
Kuruppu et al. Soluble and catalytically active endothelin converting enzyme-1 is present in cerebrospinal fluid of subarachnoid hemorrhage patients
Kennett et al. Comparative histochemical, biochemical and immunocytochemical studies of cathepsin B in human gingival
COLWELL et al. MELLITUS: NEW ASPECTS OF PATHOGENESIS
DE60034660D1 (de) Monoklonaler antikörper gegen protein c inhibitor
Elased Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry 2
WO2006030219A3 (en) Assay method

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties